RESUMEN
Rostral ventrolateral medulla (rVLM) and parapyramidal region (PPr) serve as important medullary control sites for sympathoexcitation. rVLM and PPr have direct projections to the intermediolateral cell column (IML) that are thought to be important in maintaining mean arterial blood pressure (MAP). Substance P (SP) is found in PPr neurons and in and near the subretrofacial area of the rVLM. At least some of these cells project to the IML. We investigated the involvement of SP at the IML in mediating rVLM- and PPr-evoked pressor responses in the chloralose-anesthetized cat. Pressor responses to electrical and chemical PPr and rVLM stimulation were altered after intrathecal injection, at the level of the T1-T3 spinal cord, of either SP antagonist [D-Pro(2), D-Phe(7), D-Trp(9)]-SP, SP antagonist CP 96,345, or SP antiserum. Although MAP and heart rate responses to PPr stimulation were attenuated by intrathecal SP antagonists or antiserum, MAP responses to rVLM stimulation were augmented. Previous studies have revealed differences in transmitters associated with these two areas, even though the general response of both areas is sympathoexcitatory. The present study implies that the identical substance may increase or decrease the MAP response depending on the pathway activated.
Asunto(s)
Bulbo Raquídeo/fisiología , Sustancia P/fisiología , Animales , Compuestos de Bifenilo/farmacología , Presión Sanguínea/efectos de los fármacos , Fenómenos Fisiológicos Cardiovasculares , Sistema Cardiovascular/efectos de los fármacos , Gatos , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica/métodos , Frecuencia Cardíaca/efectos de los fármacos , Homocisteína/análogos & derivados , Homocisteína/farmacología , Sueros Inmunes/farmacología , Inyecciones Espinales , Sustancia P/agonistas , Sustancia P/antagonistas & inhibidores , Sustancia P/inmunología , Factores de TiempoRESUMEN
PIP: The blood-serum iron concentrations were examined in women using Anagravid (Polfa) as an oral contraceptive (OC). The examined subjects used the preparation for 6 months and their results were compared with those women not using a progestogen contraceptive. The results underwent statistical analysis. It was demonstrated that in the group of patients using Anagravid, the blood-serum iron concentrations were significantly higher when compared with those women who did not receive OCs. The mechanism of this phenomenon remains unclear. (author's modified)^ieng
